Clinical Trials Directory

Trials / Completed

CompletedNCT07050082

Cystoinflation to Prevent Bladder Injury in Cases of Placenta Accreta Spectrum

Cystoinflation to Prevent Bladder Injury in Cases of Placenta Accreta Spectrum , a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Placenta accreta spectrum (PAS) disorders are associated with a high risk of bladder injury .leading to increased morbidity. Cystoinflation, involving controlled retrograde bladder filling, has been proposed as a technique to improve intraoperative visualization and reduce bladder injuries. Objective To evaluate the efficacy and safety of cystoinflation in preventing bladder injuries in cases of PAS. Methods This randomized controlled trial included 84 women diagnosed with PAS, allocated equally into cystoinflation and control groups. The cystoinflation group underwent bladder filling with 200 mL saline to facilitate dissection, while the control group did not. Primary outcome measures included the incidence of bladder injury, operative time. Data were analyzed using appropriate statistical tests with significance set at p\<0.05.

Detailed description

The global incidence of placenta accreta spectrum (PAS) disorders are rising in parallel with the increasing rates of cesarean delivery, posing significant challenges in obstetric practice due to its association with severe maternal morbidity and mortality . PAS encompasses a spectrum of abnormal placental adherence, which can lead to life-threatening hemorrhage during delivery. In response to the limitations of traditional terminology (placenta accreta, increta, percreta), the International Federation of Gynecology and Obstetrics introduced a standardized classification under the umbrella of PAS disorders, aiming to improve diagnostic clarity and clinical management. Surgical management recognized as the standard of care for invasive placentation .However, this procedure carries a substantial risk, with severe maternal morbidity rates reaching 40-50%, primarily due to hemorrhage and injury to adjacent organs. In extreme cases, maternal mortality may reach up to 7% .The complexity of the surgery is heightened by the high risk of adjacent organ injury, with an adjusted odds ratio of 8.2 for damage to nearby structures . Among these complications, urinary tract injury is notably prevalent. Risk factors include the depth and lateral extension of placental invasion, the extent of intraoperative blood loss, and the number of prior cesarean sections . Urinary tract trauma occurs in approximately 29% of PAS-related surgeries, with bladder lacerations accounting for 76%, ureteral injuries for 17%, and genitourinary fistulas for 5% . Although injuries to the bowel, pelvic vasculature, and nerves are less common, they remain clinically significant . Bladder injury, in particular, has profound implications, contributing to prolonged operative time, urinary tract infections, voiding dysfunction, and extended catheterization, all of which adversely affect a patient's physical and psychological well-being .While routine preoperative bladder catheterization aids in visualizing the surgical field, it often fails to prevent bladder injury in cases with dense adhesions. This study aims to assess the efficacy and safety of bladder filling with 200 cc saline during bladder dissection in women diagnosed with PAS.

Conditions

Interventions

TypeNameDescription
PROCEDUREBladder dissection after filling with 200 cc saline solutionBladder filling after entering peritoneal cavity, then bladder dissection done to avoid bladder injury
OTHERBladder dissection with empty bladderAfter entering peritoneal cavity, bladder dissection done with empty bladder

Timeline

Start date
2023-06-01
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2025-07-03
Last updated
2025-09-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07050082. Inclusion in this directory is not an endorsement.